General Methods
All commercial reagents are of ACS reagent grade and used as supplied. DMF and CH 2 Cl 2 were dried over 4 Å molecular sieves and CaH, respectively, and distilled before use. Metal precursors were prepared following the established procedures. [1] [2] [3] Column chromatography was carried out on Merck silica gel 60 (230-400 mesh).
Melting points were obtained with an electrothermal capillary apparatus and were uncorrected. Optical rotations were measured using Rudolph Research Autopol Ⅲ digital polarimeter using a sodium lamp (D line, 589 nm) and are reported in degrees with concentration in unit of 10 mg mL -1 . 1 H and 13 C spectra were recorded using a Bruker AMX 300 or DRX 500 spectrometer and all chemical shifts were reported as δ in parts per million (ppm) downfield from tetramethylsilane (δ = 0.0). The Synthesis of intermediates 6 has been followed by the procedure reported in the reference 4 in the main paper. More specifically, compounds 5 and 6 have been used in the synthesis of other tripodal receptors, and their characterization data are included in a submitted paper.
2-[(3,5-Bis{[4-(3-hydroxyphenyl)-4,5-dihyrooxazol-2-yl]methyl}-2,4,6-triethyl)-phenyl]methyl-4-(3-hydroxyphenyl)-4,5-dihydrooxazole-4-yl]phenoxy}methyl-4-pyridine (1b)
. NaH (350 mg, 14.55 mmol) was added in small portions into a solution of 6b (1.0 g, 1.46 mmol) in dry DMF (20 mL). After hydrogen gas evolution is subsided, the mixture was stirred at room temperature for 30 min. A solution of 4-bromomethylpyridine (1.84 g, 7.27 mmol) in CH 2 Cl 2 (100 mL) was introduced into the reaction mixture using a syringe. The resulting mixture was stirred at room temperature for 24 h, and it was poured into an Erlenmeyer flask containing a mixture of water/dichloromethane. The organic layer was separated, washed with brine, dried over anhydrous MgSO 4 , and concentrated to dryness. The residue was purified by column chromatography (MeOH:EtOAc, 3:7) to afford the desired pyridyl-tris(oxazoline) 1b as white powders (0.75 g, 54%). (4-Bromomethylpyridine was freshly prepared before use by the following method: A saturated aqueous Na 2 CO 3 solution was added to a stirred solution of 4-bromomethylpyridine·HBr (1.84 g, 7.27 mmol) in distilled water (50 ml) at 0 ℃, at such a rate to maintain the temperature <5 ℃ and to reach pH ~7. Then, 4-bromomethylpyridine was extracted with dichloromethane, dried over anhydrous MgSO 4 , and filtered. The filtrate (100 ml) was used without further purification. 
2-[(3,5-Bis{[4-(3-hydroxyphenyl)-4,5-dihyrooxazol-2-yl]methyl}-2,4,6-trimethyl)-phenyl]methyl-4-(3-hydroxyphenyl)-4,5-dihydrooxazole-4-yl]phenoxy}methyl-4-pyridine (1a
Cage 2b. This complex was assembled by mixing tripodal oxazoline 1b with transPd(OTf) 2 (PEt 3 ) 2 in a molar ratio of 2:3 in CH 2 Cl 2 at room temperature for 5 min.
Removal of the solvent in vacuo afforded the desired cage in a quantitative yield. The peak at 1.2 ppm in the 1 H NMR spectrum is owing to the presence of "free" Et 3 P because a slight excess amount of the palladium source was used: 
